作者
Adam Voshall,Daniel J. Gutzmann,Ignasi Bofill Verdaguer,Marcell Crispim,Cory H. T. Boone,Audrey L. Atkin,Kenneth W. Nickerson
摘要
ABSTRACT Farnesol salvage, a two-step pathway converting farnesol to farnesyl pyrophosphate (FPP), occurs in bacteria, plants, and animals. This paper investigates the presence of this pathway in fungi. Through bioinformatics, biochemistry, and physiological analyses, we demonstrate its absence in the yeasts Saccharomyces cerevisiae and Candida albicans , suggesting a likely absence across fungi. We screened 1,053 fungal genomes, including 34 from C. albicans , for potential homologs to four genes ( Arabidopsis thaliana AtFOLK , AtVTE5 , AtVTE6 , and Plasmodium falciparum PfPOLK ) known to accomplish farnesol/prenol salvage in other organisms. Additionally, we showed that 3 H-farnesol was not converted to FPP or any other phosphorylated prenol, and exogenous farnesol was not metabolized within 90 minutes at any phase of growth and did not rescue cells from the toxic effects of atorvastatin, but it did elevate the levels of intracellular farnesol (F i ). All these experiments were conducted with C. albicans . In sum, we found no evidence for farnesol salvage in fungi. IMPORTANCE The absence of farnesol salvage constitutes a major difference in the metabolic capabilities of fungi. In terms of fungal physiology, the lack of farnesol salvage pathways relates to how farnesol acts as a quorum-sensing molecule in Candida albicans and why farnesol should be investigated for use in combination with other known antifungal antibiotics. Its absence is essential for a model (K. W. Nickerson et al., Microbiol Mol Biol Rev 88:e00081-22, 2024), wherein protein farnesylation, protein chaperones, and the unfolded protein response are combined under the unifying umbrella of a cell’s intracellular farnesol (F i ). In terms of human health, farnesol should have at least two different modes of action depending on whether those cells have farnesol salvage. Because animals have farnesol salvage, we can now see the importance of dietary prenols as well as the potential importance of farnesol in treating neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis.